Literature DB >> 16371473

Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria.

Frank P Mockenhaupt1, Jakob P Cramer, Lutz Hamann, Miriam S Stegemann, Jana Eckert, Na-Ri Oh, Rowland N Otchwemah, Ekkehart Dietz, Stephan Ehrhardt, Nicolas W J Schröder, Ulrich Bienzle, Ralf R Schumann.   

Abstract

Genetic host factors play a substantial role in susceptibility to and severity of malaria, which continues to cause at least one million deaths per year. Recently, members of the toll-like receptor (TLR) family have been shown to be involved in recognition of the etiologic organism Plasmodium falciparum: The glycosylphosphatidylinositol anchor induces signaling in host cells via TLR-2 and -4, whereas hemozoin-induced immune activation involves TLR-9. Binding of microbial ligands to the respective TLRs triggers the release of proinflammatory cytokines via the TLR/IL-1 receptor (TIR) domain and may contribute to the host response in malaria, including cytokine induction and fever. In a case-control study among 870 Ghanaian children, we examined the influence of TLR-2, -4, and -9 polymorphisms in susceptibility to severe malaria. TLR-2 variants common in Caucasians and Asians were completely absent. However, we found a rare previously undescribed mutation (Leu658Pro), which impairs signaling via TLR-2. We failed to detect any polymorphisms within the TLR-9 Toll/IL-1 receptor domain. Two frequent TLR-9 promoter polymorphisms did not show a clear association with malaria severity. In contrast, the TLR-4-Asp299Gly variant occurred at a high rate of 17.6% in healthy controls and was even more frequent in severe malaria patients (24.1%, P < 0.05). Likewise, TLR-4-Thr399Ile was seen in 2.4% of healthy children and in 6.2% of patients (P = 0.02). TLR-4-Asp299Gly and TLR-4-Thr399Ile conferred 1.5- and 2.6-fold increased risks of severe malaria, respectively. These findings suggest TLR4-mediated responses to malaria in vivo and TLR-4 polymorphisms to be associated with disease manifestation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16371473      PMCID: PMC1324982          DOI: 10.1073/pnas.0506803102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

1.  Tuberculosis in Ghana: social stigma and compliance with treatment.

Authors:  S D Lawn
Journal:  Int J Tuberc Lung Dis       Date:  2000-12       Impact factor: 2.373

2.  Malaria susceptibility and CD36 mutation.

Authors:  T J Aitman; L D Cooper; P J Norsworthy; F N Wahid; J K Gray; B R Curtis; P M McKeigue; D Kwiatkowski; B M Greenwood; R W Snow; A V Hill; J Scott
Journal:  Nature       Date:  2000-06-29       Impact factor: 49.962

3.  Plasmodium falciparum glycosylphosphatidylinositol-induced TNF-alpha secretion by macrophages is mediated without membrane insertion or endocytosis.

Authors:  M Vijaykumar; R S Naik; D C Gowda
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

4.  Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite.

Authors:  M A Campos; I C Almeida; O Takeuchi; S Akira; E P Valente; D O Procópio; L R Travassos; J A Smith; D T Golenbock; R T Gazzinelli
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

5.  Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation.

Authors:  A M Moormann; A D Sullivan; R A Rochford; S W Chensue; P J Bock; T Nyirenda; S R Meshnick
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

6.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.

Authors:  E A Kurt-Jones; L Popova; L Kwinn; L M Haynes; L P Jones; R A Tripp; E E Walsh; M W Freeman; D T Golenbock; L J Anderson; R W Finberg
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

7.  A molecular marker for chloroquine-resistant falciparum malaria.

Authors:  A Djimdé; O K Doumbo; J F Cortese; K Kayentao; S Doumbo; Y Diourté; D Coulibaly; A Dicko; X Z Su; T Nomura; D A Fidock; T E Wellems; C V Plowe
Journal:  N Engl J Med       Date:  2001-01-25       Impact factor: 91.245

8.  Quantifying genetic and nongenetic contributions to malarial infection in a Sri Lankan population.

Authors:  M J Mackinnon; D M Gunawardena; J Rajakaruna; S Weerasingha; K N Mendis; R Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

9.  A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection.

Authors:  E Lorenz; J P Mira; K L Cornish; N C Arbour; D A Schwartz
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

10.  Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria.

Authors:  A J Luty; J F Kun; P G Kremsner
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

View more
  101 in total

1.  Reorienting our view of particle-based adjuvants for subunit vaccines.

Authors:  Steven R Little
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

Review 2.  TLR4 polymorphisms and disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Ali A Shah; Sheeba Murad Mall; Shazia Choudhary; Tahir Hussain; Iltaf Ahmed; Syed Fazal Jalil; Muhammad Imran Raza
Journal:  Inflamm Res       Date:  2012-01-26       Impact factor: 4.575

Review 3.  Into the eye of the cytokine storm.

Authors:  Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

Review 4.  Molecular Neuro-Pathomechanism of Neurocysticercosis: How Host Genetic Factors Influence Disease Susceptibility.

Authors:  Naina Arora; Shweta Tripathi; Reshma Sao; Prosenjit Mondal; Amit Mishra; Amit Prasad
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

Review 5.  Malarial fever: hemozoin is involved but Toll-free.

Authors:  Ralf R Schumann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-01       Impact factor: 11.205

Review 6.  Toll-like receptors in defense and damage of the central nervous system.

Authors:  Rajagopal N Aravalli; Phillip K Peterson; James R Lokensgard
Journal:  J Neuroimmune Pharmacol       Date:  2007-04-03       Impact factor: 4.147

7.  Toll like receptor 4 D299G associates with disease progression in Caucasian patients with chronic HBV infection: relationship with gender.

Authors:  Annarosa Cussigh; Carlo Fabris; Giovanna Fattovich; Edmondo Falleti; Sara Cmet; Davide Bitetto; Eleonora Bignulin; Pierluigi Toniutto
Journal:  J Clin Immunol       Date:  2012-10-24       Impact factor: 8.317

Review 8.  Malarial hemozoin: from target to tool.

Authors:  Lorena M Coronado; Christopher T Nadovich; Carmenza Spadafora
Journal:  Biochim Biophys Acta       Date:  2014-02-17

Review 9.  Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.

Authors:  Anne E P Frosch; Chandy C John
Journal:  Expert Rev Anti Infect Ther       Date:  2012-11       Impact factor: 5.091

10.  Toll-like receptors TLR4 (Asp299Gly and Thr399Ile) and TLR2 (Arg677Trp and Arg753Gln) gene polymorphisms in end-stage renal disease patients on peritoneal dialysis.

Authors:  Kamini Singh; Kashi Nath Prasad; Priyanka Mishra; Jahanarah Khatoon; Narayan Prasad; Amit Gupta; Janmejai Kumar Srivastava
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.